XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 29, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Oct 1, 2023 | (Q2)Jul 2, 2023 | (Q1)Apr 2, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0.33%11.2B | 8.67%2.89B | -1.40%2.99B | -16.70%2.07B | 8.87%3.25B | 7.16%11.16B | 0.18%2.66B | 11.06%3.03B | 4.96%2.49B | 2.99B |
Operating revenue | 0.33%11.2B | 8.67%2.89B | -1.40%2.99B | -16.70%2.07B | 8.87%3.25B | 7.16%11.16B | 0.18%2.66B | 11.06%3.03B | 4.96%2.49B | --2.99B |
Cost of revenue | -4.31%5.9B | -13.35%1.33B | 5.09%1.75B | -8.65%1.24B | -1.78%1.58B | 4.17%6.17B | 1.75%1.53B | 3.09%1.67B | -1.05%1.36B | 1.61B |
Gross profit | 6.06%5.3B | 38.75%1.56B | -9.38%1.23B | -26.35%833.75M | 21.25%1.68B | 11.09%5B | -1.89%1.12B | 22.71%1.36B | 13.21%1.13B | 1.38B |
Operating expense | -3.69%2.37B | -9.33%622.73M | -5.19%591.92M | -6.54%541.58M | 5.78%618.62M | 9.32%2.46B | 8.18%686.82M | 13.12%624.3M | 6.62%579.47M | 584.8M |
Selling and administrative expenses | -3.69%2.37B | -9.33%622.73M | -5.19%591.92M | -6.54%541.58M | 5.78%618.62M | 9.32%2.46B | 8.18%686.82M | 13.12%624.3M | 6.62%579.47M | --584.8M |
-General and administrative expense | ---- | ---- | ---- | -6.54%541.58M | 5.78%618.62M | 9.32%2.46B | ---- | ---- | --579.47M | --584.8M |
Operating profit | 15.55%2.93B | 114.43%935.61M | -12.93%640.8M | -47.13%292.16M | 32.59%1.06B | 12.88%2.53B | -14.43%436.32M | 32.22%735.95M | 21.05%552.63M | 797.52M |
Net non-operating interest income expense | -9.14%-165.66M | -6.53%-40.14M | -11.47%-44.32M | -12.85%-41.37M | -5.67%-39.82M | -10.34%-151.79M | -5.89%-37.68M | -12.37%-39.76M | -9.72%-36.66M | -37.69M |
Non-operating interest income | ---- | ---- | 7.56%2.25M | -16.41%2.94M | 1.82%1.79M | 283.22%9.73M | 108.62%2.37M | 218.93%2.09M | 802.57%3.51M | --1.75M |
Non-operating interest expense | 2.57%165.66M | 0.22%40.14M | 11.28%46.56M | 10.30%44.31M | 5.50%41.61M | 15.29%161.51M | 9.07%40.06M | 16.13%41.84M | 18.85%40.17M | --39.44M |
Other net income (expense) | -37.22%-287.68M | -118.35%-172.41M | -81.71%-77.74M | 93.57%-4.91M | -5,282.85%-31.38M | -10.53%-209.65M | 28.98%-78.96M | 11.16%-42.78M | -288.92%-76.45M | -583K |
Special income (charges) | 86.23%-29.04M | 103.72%3.54M | -103.01%-77.26M | 93.59%-4.94M | -3,770.65%-31.39M | -10.85%-210.93M | 20.28%-95.07M | 12.13%-38.06M | -418.52%-76.99M | ---811K |
-Less:Restructuring and merger&acquisition | 6,483.90%29.04M | ---3.54M | --27.64M | 1,434.32%4.94M | --0 | -77.83%441K | --0 | --0 | ---370K | --811K |
-Write off | ---- | ---- | 30.40%49.63M | --0 | --31.39M | 11.79%210.48M | -19.11%95.07M | -12.13%38.06M | 421.01%77.36M | --0 |
Other non- operating income (expenses) | -20,369.67%-258.64M | -1,192.43%-175.95M | 89.94%-475K | -95.72%23K | -96.05%9K | 115.18%1.28M | 99.80%16.11M | 2.48%-4.72M | 111.16%537K | --228K |
Income before tax | 13.91%2.47B | 126.19%723.06M | -20.61%518.75M | -44.06%245.87M | 29.90%986.26M | 13.29%2.17B | -11.96%319.68M | 38.12%653.41M | 8.94%439.52M | 759.26M |
Income tax | -18.51%252.7M | -150.40%-73.53M | -46.27%72.45M | 99.71%64.98M | 9.73%188.81M | 13.89%310.08M | 11.48%-29.37M | 83.21%134.84M | -62.99%32.54M | 172.07M |
Net income | 19.31%2.22B | 128.22%796.59M | -13.94%446.3M | -55.55%180.89M | 35.81%797.45M | 13.19%1.86B | -11.92%349.04M | 29.81%518.58M | 28.97%406.98M | 587.19M |
Net income continuous Operations | 19.31%2.22B | 128.22%796.59M | -13.94%446.3M | -55.55%180.89M | 35.81%797.45M | 13.19%1.86B | -11.92%349.04M | 29.81%518.58M | 28.97%406.98M | --587.19M |
Minority interest income | 0 | |||||||||
Net income attributable to the parent company | 19.31%2.22B | 128.22%796.59M | -13.94%446.3M | -55.55%180.89M | 35.81%797.45M | 13.19%1.86B | -11.92%349.04M | 29.81%518.58M | 28.97%406.98M | 587.19M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 19.31%2.22B | 128.22%796.59M | -13.94%446.3M | -55.55%180.89M | 35.81%797.45M | 13.19%1.86B | -11.92%349.04M | 29.81%518.58M | 28.97%406.98M | 587.19M |
Basic earnings per share | 20.52%11.22 | 130.29%4.03 | -13.08%2.26 | -54.68%0.92 | 36.05%4 | 13.26%9.31 | -11.62%1.75 | 30.00%2.6 | 29.30%2.03 | 2.94 |
Diluted earnings per share | 20.53%10.92 | 130.59%3.92 | -12.70%2.2 | -55.05%0.89 | 36.49%3.89 | 13.82%9.06 | -11.46%1.7 | 29.90%2.52 | 29.41%1.98 | 2.85 |
Dividend per share | 22.98%5.48 | 14.93%1.37 | 14.93%1.37 | 32.24%1.37 | 32.24%1.37 | 15.02%4.456 | 15.06%1.192 | 15.06%1.192 | 14.98%1.036 | 1.036 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |